Stay updated on Tagraxofusp in CD123+ AML Clinical Trial

Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Record history now includes Revision: v3.4.3 and no longer lists Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:41:08.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.4.2) to the record history and removed the funding-status notice along with the earlier Revision: v3.4.1 entry.
    Difference
    0.9%
    Check dated 2026-02-11T14:12:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice about government funding status is now displayed at the top of the page and the revision indicator updated to v3.4.1 (replacing v3.4.0); these are UI/metadata changes and do not affect the study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T10:20:30.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The Record History view now includes a glossary option, color-coded additions and deletions, and explicit version labels to show how study record changes are presented.
    Difference
    1%
    Check dated 2026-01-28T06:16:05.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The study record versions now include a new revision entry v3.3.4 and remove v3.3.3 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:16:23.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page history now shows a new revision label 'Revision: v3.3.3', and the entries for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' appear to be removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T09:42:12.000Z thumbnail image

Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.